kensey nash
-
Biologics
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
DSM will commence all-cash tender offer in May Tender Offer expected to be completed by June 30, 2012 EXTON, Pa., May…
Read More » -
Kensey Nash Posts 26% Q4 Profit Growth, But Shows Overall Profit Decline For Fiscal 2010
Kensey Nash (NASDAQ:KNSY), a medical device company that provides technologies for medical procedures, saw its fourth quarter profits for 2010…
Read More » -
Kensey Nash and Arthrex Announce Strategic Agreement for Extracellular Matrix Products
EXTON, Pa., June 24, 2010 /PRNewswire via COMTEX/ –Kensey Nash Corporation (Nasdaq: KNSY), a regenerative medicine company, and Arthrex, Inc.,…
Read More » -
Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results
EXTON, Pa., Jan 28, 2010 /PRNewswire via COMTEX/ — Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that…
Read More »